| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0085 | 0.9 |